Patents by Inventor Maria Parkhurst

Maria Parkhurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
    Patent number: 8252545
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: August 28, 2012
    Assignee: The United States of America, as represented by the Secretary Department of Health and Human Services
    Inventors: Patrick Hwu, Rejean LaPointe, Steven A. Rosenberg, Maria Parkhurst
  • PEPTIDES OF A MELANOMA ANTIGEN AND THEIR USE IN DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC METHODS
    Publication number: 20100279950
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Application
    Filed: May 19, 2010
    Publication date: November 4, 2010
    Applicant: The U.S. of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Patrick Hwu, Rejean LaPointe, Steven A. Rosenberg, Maria Parkhurst
  • Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
    Patent number: 7749967
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: July 6, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services.
    Inventors: Patrick Hwu, Rejean LaPointe, Steven A. Rosenberg, Maria Parkhurst
  • PEPTIDES OF A MELANOMA ANTIGEN AND THEIR USE IN DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC METHODS
    Publication number: 20090010953
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Application
    Filed: August 21, 2008
    Publication date: January 8, 2009
    Applicant: GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT.
    Inventors: Patrick Hwu, Rejean LaPointe, Steven A. Rosenberg, Maria Parkhurst
  • Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
    Patent number: 7419957
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: September 2, 2008
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Patrick Hwu, Rejean LaPointe, Steven A. Rosenberg, Maria Parkhurst
  • Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
    Publication number: 20050065077
    Abstract: Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
    Type: Application
    Filed: August 22, 2002
    Publication date: March 24, 2005
    Inventors: Patrick Hwu, Rejean LaPointe, Steven Rosenberg, Maria Parkhurst